|
The Bugs The Bugs The Drugs
|
tarix | 12.01.2019 | ölçüsü | 452 b. | | #95234 |
|
The Bugs The Bugs The Drugs ‘La Resistance’ Clinical Scenarios from the Children’s Hospital
Earliest bacterial fossil is 3.5 billion years old Earliest bacterial fossil is 3.5 billion years old - Cyanobacteria from Archean rock (W. Australia)
- Small, unicellular
- Aquatic & photosynthetic (chloroplast in plants)
10 times as many bacteria as human cells in the body (~1014 versus 1013) 10 times as many bacteria as human cells in the body (~1014 versus 1013) 500 to 1000 species of bacteria live in the human gut and a similar number on the skin On the whole, symbiotic relationship between bacteria and host
Simple, efficient and highly adaptable Simple, efficient and highly adaptable - Free floating DNA (nucloid) with plasmids
β-lactams β-lactams Penicillin, Amoxicillin O/IV Flucloxacillin (O)/IV Piperacillin/tazobactam IV Amoxicillin/clavulanate O/IV Meropenem IV
Aminoglycosides IV Aminoglycosides IV - Gentamycin
- Tobramycin
- Amikacin
Glycopeptides IV
Bacteriostatic Antibiotics Bacteriostatic Antibiotics - Inhibit bacterial cell growth
- Need intact immune system to fight infection
- Clindamycin, Linezolid, Macrolides
Bacteriocidal Antibiotics
Clindamycin Clindamycin - Binds to 50s ribosomal subunit of the bacteria
- Inhibits protein synthesis
- Changes in the cell wall surface which decreases adherence of bacteria to host cells and increases intracellular killing of organisms
- Reduction in toxin production in
- Staphylococcus aureus and Group A Streptococcus TSS
- Exerts an extended postantibiotic effect against some strains of bacteria (attributed to persistence of the drug at the ribosomal binding site)
High (>90%) High (>90%) - Cefalexin
- Clindamycin
- Rifampicin
- Fusidic acid
- Levofloxacin (99%)
- Metronidazole
- Linezolid (100%)
Do not use flucloxacillin (clindamycin) suspensions!! Do not use flucloxacillin (clindamycin) suspensions!! flucloxacillin cefalexin
Penetration of various drugs in CSF Penetration of various drugs in CSF - Increases with inflammation, lipid solubility
- Decreases with molecular weight, protein binding
Good - Good
- Cefotaxime
- Ceftriaxone
- Meropenem
- Metronidazole
- Ciprofloxacin
- Vancomycin*
Flucloxacillin/Cefalexin Flucloxacillin/Cefalexin Clindamycin/Fluoroquinolones + Rifampicin/Fusidic acid [3rd generation cephalosporins]
Ampicillin + Gentamicin for Enterococcus spp. Ampicillin + Gentamicin for Enterococcus spp. Flucloxacillin + Gentamcin for MSSA endocarditis Double Gram -ve for Pseudomonas spp. ?? Add Clindamycin in SA/GAS TSS
Spectrum of activity/Sensitivities Spectrum of activity/Sensitivities Oral/IV forms Static/Cidal PK/PD parameters Bioavailability/palatability Achievable plasma levels/tissue penetration Renal/Hepatic dysfunction
Decreased Permeability Decreased Permeability - Porin mutations, efflux system
Enzymatic Drug Modification - Β-Lactamase (ESBL), carbapenemase production
Altered Drug Target - PBP2’MRSA, DNA Gyrase mutation
Metabolic Bypass Tolerance - Inhibition/killing discrepancy
8yo boy in A&E with 5cm boil on buttocks 8yo boy in A&E with 5cm boil on buttocks On Flucloxacillin for 3 days – not improving History of recurrent boils / cellulitis in last year Obs stable, clinically well
I&D I&D Co-amoxiclav I&D + co-amoxiclav Septrin I&D + Septrin
I&D I&D Co-amoxiclav I&D + co-amoxiclav Septrin I&D + Septrin
Swap and swab! Swap and swab! I&D is key (sometimes enough) What abx are effective for MRSA? - TMP/SMX, Erythomycin, Clindamycin (variable, D-test)
- Rifampicin, Fusidic acid (never alone)
- Vancomycin, Teicoplanin
- Daptomycin, Linezolid
What is not effective: ANY β-lactam (PBP2’ mutation)
8 years male, short bowel, TPN dependent 8 years male, short bowel, TPN dependent Previous central line (Broviac) infections Frequent hospitalisation Febrile 39.5c in A&E, Hypotensive Needing fluid bolus
Ceftriaxone Ceftriaxone Vancomycin + Ceftriaxone Piperacillin/Tazobactam Ciprofloxacin Vancomycin + Ciprofloxacin Meropenem
Ceftriaxone Ceftriaxone Vancomycin + Ceftriaxone Piperacillin/Tazobactam Ciprofloxacin Vancomycin + Ciprofloxacin Meropenem
At risk for hospital acquired MDR infections: At risk for hospital acquired MDR infections: - ESBL – plasmid mediated
- Klebsiella, E.coli, Enterobacter spp.
- AmpC – chromosomally induced
- Serretia, Acinetobacter, Citrobacter, Enterobacter spp.
- CRE – carbapenem resistant Enterobacteriaceae
No Cephalosporins Ciprofloxacin/mero (+/- Glycopeptide/AG if CVL) if septic
3 yo old female 3 yo old female Unwell for 3 days with coryza/headaches (January) Now in A&E, T 40c, Fluid bolusesx3 Respiratory Distress Rapid sequence intubation Diffuse erythrodermic rash, rapidly spreading
Oseltamivir + Cefuroxime Oseltamivir + Cefuroxime Cefuroxime + Clarythromycin Cefuroxime + Clindamycin Oseltamivir + Cefuroxime + Clindamycin Oseltamivir + Vancomycin + Meropenem
Oseltamivir + Cefuroxime Oseltamivir + Cefuroxime Cefuroxime + Clarythromycin Cefuroxime + Clindamycin Oseltamivir + Cefuroxime + Clindamycin Oseltamivir + Vancomycin + Meropenem
Viral-Bacterial co-infections, especially with flu Viral-Bacterial co-infections, especially with flu Add Clindamycin to Penicillin/Cephalosporin - Inhibition production of TSST-1 by 95%*
Cefuroxime dose – always 50mg/kg! IVIG
2 yo with history of earache and fever 2 yo with history of earache and fever Secondary development of mastoiditis Transfer to Alder Hey for further management Bloods Wbc 17.5, N11.6, CRP 150 CT scan and Drainage in theatre
Cefotaxime + Amoxicillin Cefotaxime + Amoxicillin Amoxicillin + Metronidazole Cefotaxime + Metronidazole Vancomycin + Cefotaxime + Metronidazole Vancomycin + Meropenem
Cefotaxime + Amoxicillin Cefotaxime + Amoxicillin Amoxicillin + Metronidazole Cefotaxime + Metronidazole Vancomycin + Cefotaxime + Metronidazole Vancomycin + Meropenem
Microbiology from drainage negative Patient improving clinically - No fever within 48-72 hours
- CRP down to 58 then 6 after 1 week therapy
Surgeons want to send patient home Still no agreement whether intracranial collection real…
Switch to oral co-amoxiclav x 4 wks Switch to oral co-amoxiclav x 4 wks Switch to oral cefalexin and metronidazole x 6 wks Switch to oral septrin and metronidazole x 6 wks Continue IV ceftriaxone + metronidazole x 6 wks
Switch to oral co-amoxiclav x 4 wks Switch to oral co-amoxiclav x 4 wks Switch to oral cefalexin and metronidazole x 6 wks Switch to oral septrin and metronidazole x 6 wks Continue IV ceftriaxone + metronidazole x 6 wks
No Consensus on IV to oral switch No Consensus on IV to oral switch IV 6 weeks with cefotaxime + metro standard Switch at 2-3 weeks to oral agent only if uncomplicated and good response - Oral agent with good CSF penetration
Need for multicenter study
3 month old female 3 month old female Gastroschisis repair at birth TPN dependent, Central line in situ Colonised with CRE Fever 38.9c, unwell, vomiting Started on Teicoplanin + Gentamicin IV
Staphylococcus epidermidis in Blood culture Staphylococcus epidermidis in Blood culture Teico MIC=2µ=mg/L, vanco MIC=2mg/L Both Sensitive - Breakpoint is 2 for vancomycin, 4 for Teicoplanin
No access to Teicoplanin levels
Continue with Teicoplanin high dose -10 mg/kg od Continue with Teicoplanin high dose -10 mg/kg od Add Rifampicin to Teicoplanin Change to Vancomycin and aim levels 15-20mg/L Change to Linezolid Change to Daptomycin
Continue with Teicoplanin high dose -10 mg/kg od Continue with Teicoplanin high dose -10 mg/kg od Add Rifampicin to HD Teicoplanin Change to Vancomycin and aim levels 15-20mg/L Change to Linezolid Change to Daptomycin
Switched to vancomycin 15 mg/kg q8hrs Switched to vancomycin 15 mg/kg q8hrs Blood culture taken when switched is still +ve for same organism Through level of Vancomycin - Before third dose – 5.6mg/L, dose ↑30 mg/kg
- 24 hours later – 6.0mg/L, dose increased to ↑35mg/kg
- 24 later – 8.9mg/L
Repeat Blood culture 4 days from initial +ve culture still positive…
Add oral rifampicin Increase dose of vancomycin to 40 mg/kg Switch to linezolid Switch to daptomycin Take line out
Add oral rifampicin Add oral rifampicin Increase dose of vancomycin by 25% Switch to linezolid Switch to daptomycin Take line out
Started on linezolid IV Started on linezolid IV - ?Role for loading dose of Vancomycin (30mg/kg)
Repeat blood culture negative 1 week later, unwell fever, bolus of fluid Growth of yeast within 24 hours
Start Liposomal amphotericin 3mg/kg od Start Liposomal amphotericin 3mg/kg od Start Fluconazole 12mg/kg od Start Caspofungin 50mg/m2 od Start Micafungin 2mg/kg od ±Take line out
Start Liposomal amphotericin 3mg/kg od Start Liposomal amphotericin 3mg/kg od Start Fluconazole 12mg/kg od Start Caspofungin 50mg/m2 od Start Micafungin 2mg/kg od ±Take line out
Yeast Identified as Candida albicans Yeast Identified as Candida albicans Succesfully treated with - 2 week course linezolid
- 2 week course micafungin fluconazole
Know your friends and your enemies Know your friends and your enemies - Basic microbiological knowledge paramount
Drug classes and spectrum of activity - Quirks: bioavailability, taste, tissue penetration…
Be Aware of resistance - Hitting hard first then narrow spectrum…
Every clinical case is unique - Understand each antimicrobials individual strengths
- Individualised therapy in severe infection
www.bugsanddrugs.ca (www.dobugsneeddrugs.ca) www.bugsanddrugs.ca (www.dobugsneeddrugs.ca) Sandford antimicrobial guide Mandell, Sarah Long textbook Your microbiology lab Promed HPA
Dostları ilə paylaş: |
|
|